Mortality Rate and Outcomes of Omicron Variant Positive Patients with Osteoporotic Fractures: A Retrospective Study
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: During the lockdown period associated with the coronavirus disease 2019 (COVID-19) pandemic, increased mortality rates among patients with COVID-19 have been reported. This study aimed to analyze the mortality rate of osteoporotic hip fractures in patients who were COVID-19-positive after the lockdown during the Omicron period. Methods: A retrospective study was performed with 194 patients who were aged 70 years or more and diagnosed with osteoporotic hip fracture. The patients were divided into two groups according to their COVID-19 diagnoses. Surgery was performed within 10 days of diagnosis. Age, sex, past medical history, time until surgery, postoperative complications, and the primary outcome of mortality rate at 30 and 90 days were analyzed. Results: Among the 194 patients, 13 and 181 were in the COVID-19-positive and negative group, respectively. The total, 30-day, and 90-day mortality rates in the control and COVID-positive group were 11% and 0% (P=0.368), 1.7% and 0% (P=1.000), and 5.0% and 0% (P=1.000), respectively. No significant differences were observed in age, sex, history, time to surgery, postoperative complications, or postoperative mortality. In 1:1 propensity score matching, the time to surgery was 5.34 days in patients who were COVID-19-positive, and 3.00 days in patients who were COVID-19 negative, with no statistical significance (P=0.09). Age, sex, medical history, postoperative complications, and postoperative mortality were not significantly different between the groups. Conclusions: Regardless of the COVID-19 diagnosis, surgical treatment without delay is believed to result in positive outcomes in older patients with osteoporotic hip fractures, as no significant differences in mortality rate and respiratory complications were observed between patients who were COVID-19-positive and those who were COVID-19 negative.
Abstract
Background: During the lockdown period associated with the coronavirus disease 2019 (COVID-19) pandemic, increased mortality rates among patients with COVID-19 have been reported. This study aimed to analyze the mortality rate of osteoporotic hip fractures in patients who were COVID-19-positive after the lockdown during the Omicron period. Methods: A retrospective study was performed with 194 patients who were aged 70 years or more and diagnosed with osteoporotic hip fracture. The patients were divided into two groups according to their COVID-19 diagnoses. Surgery was performed within 10 days of diagnosis. Age, sex, past medical history, time until surgery, postoperative complications, and the primary outcome of mortality rate at 30 and 90 days were analyzed. Results: Among the 194 patients, 13 and 181 were in the COVID-19-positive and negative group, respectively. The total, 30-day, and 90-day mortality rates in the control and COVID-positive group were 11% and 0% (P=0.368), 1.7% and 0% (P=1.000), and 5.0% and 0% (P=1.000), respectively. No significant differences were observed in age, sex, history, time to surgery, postoperative complications, or postoperative mortality. In 1:1 propensity score matching, the time to surgery was 5.34 days in patients who were COVID-19-positive, and 3.00 days in patients who were COVID-19 negative, with no statistical significance (P=0.09). Age, sex, medical history, postoperative complications, and postoperative mortality were not significantly different between the groups. Conclusions: Regardless of the COVID-19 diagnosis, surgical treatment without delay is believed to result in positive outcomes in older patients with osteoporotic hip fractures, as no significant differences in mortality rate and respiratory complications were observed between patients who were COVID-19-positive and those who were COVID-19 negative.
참고문헌 (26)
- "WHO COVID-19 dashboard" (2023)[URL]
- Lee DW, "Genomic epidemiology of SARS-CoV-2 Omicron variants in the Republic of Korea", Sci Rep, 12, pp.22414~ (2022)[DOI]
- Shin DH, "SARS-CoV-2 omicron variant of concern : everything you wanted to know about omicron but were afraid to ask", Yonsei Med J, 63, pp.977~983 (2022)[DOI]
- Nham E, "COVID-19 vaccination in Korea : Past, present, and the way forward", J Korean Med Sci, 37, pp.e351~ (2022)[DOI]
- Simunovic N, "Surgery for hip fractures : does surgical delay affect outcomes?", Indian J Orthop, 45, pp.27~32 (2011)[DOI]
- John KJ, "In-hospital clinical complications of COVID-19 : a brief overview", Future Virol, pp.1~7 (2021)[DOI]
- Charlson ME, "Charlson comorbidity index : a critical review of clinimetric properties", Psychother Psychosom, 91, pp.8~35 (2022)[DOI]
- Wong RMY, "High charlson comorbidity index score is associated with early fracture-related complication for internal fixation of neck of femur fractures", Sci Rep, 12, pp.4749~ (2022)[DOI]
- Chung HJ, "Analyzing the risk factors of mortality after osteoporotic hip fractures using the national health insurance service sample cohort 2. 0 database", Hip Pelvis, 34, pp.150~160 (2022)[DOI]
- Levitt EB, "Association between COVID-19 and mortality in hip fracture surgery in the national COVID cohort collaborative(N3C) : a retrospective cohort study", J Am Acad Orthop Surg Glob Res Rev, 6, pp.e21~ (2022)[DOI]
- Ding L, "The impact of COVID-19 on the prevalence, mortality, and associated risk factors for mortality in patients with hip fractures : a meta-analysis", J Am Med Dir Assoc, 24, pp.846~854 (2023)[DOI]
- Slullitel PA, "Prolonged social lockdown during COVID-19 pandemic and hip fracture epidemiology", Int Orthop, 44, pp.1887~1895 (2020)[DOI]
- Clement ND, "The prevalence, mortality, and associated risk factors for developing COVID-19 in hip fracture patients : a systematic review and meta-analysis", Bone Joint Res, 9, pp.873~883 (2020)[DOI]
- Patralekh MK, "Mortality escalates in patients of proximal femoral fractures with COVID-19 : a systematic review and meta-analysis of 35 studies on 4255 patients", J Clin Orthop Trauma, 18, pp.80~93 (2021)[DOI]
- Hwang S, "Comparing the 30-day mortality for hip fractures in patients with and without COVID-19 : an updated meta-analysis", J Pers Med, 13, pp.669~ (2023)[DOI]
- Yildiz OS, "One-year mortality rate of patients operated for hip fracture during COVID-19 pandemic compared to pre-COVID-19 period", Ann Med Res, 29, pp.836~840 (2022)[DOI]
- Liu G, "The effects of COVID-19 on geriatric hip fracture management and 1-year mortality in Beijing", Orthop Surg, 14, pp.2527~2534 (2022)[DOI]
- Tripathy SK, "Thirty-day mortality of patients with hip fracture during COVID-19 pandemic and pre-pandemic periods : a systematic review and meta-analysis", World J Orthop, 12, pp.35~50 (2021)[DOI]
- Jang SY, "Analysis of the effects of COVID-19 on hip fractures in Korea without lockdown : interrupted time series analysis using a nationwide cohort", J Korean Med Sci, 38, pp.e137~ (2023)[DOI]
- Onizuka N, "Outcomes of COVID-19 negative hip fracture patients during the acute and subacute pandemic", Geriatr Orthop Surg Rehabil, 12, pp.21514593211006692~ (2021)[DOI]
- Orosz GM, "Association of timing of surgery for hip fracture and patient outcomes", JAMA, 291, pp.1738~1743 (2004)[DOI]
- Alanezi F, "A comparative study on the strategies adopted by the United Kingdom, India, China, Italy, and Saudi Arabia to contain the spread of the COVID-19 pandemic", J Healthc Leadersh, 12, pp.117~131 (2020)[DOI]
- Armocida B, "The Italian health system and the COVID-19 challenge", Lancet Public Health, 5, pp.e253~ (2020)[DOI]
- Ceylan Z, "Estimation of COVID-19 prevalence in Italy, Spain, and France", Sci Total Environ, 729, pp.138817~ (2020)[DOI]
- Unruh L, "A comparison of 2020 health policy responses to the COVID-19 pandemic in Canada, Ireland, the United Kingdom and the United States of America", Health Policy, 126, pp.427~437 (2022)[DOI]
- Sachs JD, "Comparing COVID-19 control in the Asia-Pacific and north atlantic regions", Asian Econ Pap, 20, pp.30~54 (2021)[DOI]